Wed, December 13, 2017
Tue, December 12, 2017
Mon, December 11, 2017
Fri, December 8, 2017

Joanne Wuensch Upgraded (ABT) to Buy and Increased Target to $65 on, Dec 12th, 2017

Joanne Wuensch of BMO Capital, Upgraded "Abbott Laboratories" (ABT) to Buy and Increased Target from $58 to $65 on, Dec 12th, 2017.

Joanne has made no other calls on ABT in the last 4 months.



There are 4 other peers that have a rating on ABT. Out of the 4 peers that are also analyzing ABT, 3 agree with Joanne's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Amit Hazan of "Citigroup" Maintained at Hold with Increased Target to $59 on, Thursday, October 19th, 2017
  • David Lewis of "Morgan Stanley" Maintained at Hold with Increased Target to $60 on, Thursday, October 19th, 2017
  • Michael Weinstein of "JP Morgan" Initiated at Hold and Held Target at $60 on, Friday, October 6th, 2017


This is the rating of the analyst that currently disagrees with Joanne


  • Matthew Taylor of "Barclays" Maintained at Buy with Increased Target to $64 on, Thursday, October 19th, 2017